Amgen's stock price fell 7% after the results of the clinical trial of its experimental weight loss drug were released
2025-06-24 02:55:50

Amgen was last down 7% after the company released clinical trial results for its experimental weight-loss drug.
Email Subscription
Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.
ASIA TECH WIRE

Grasp technology trends

Download